Galectin Therapeutics (GALT) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.17% |
| Dec 31, 2025 | 9.25% |
| Sep 30, 2025 | -5.39% |
| Jun 30, 2025 | -1.76% |
| Mar 31, 2025 | -20.11% |
| Dec 31, 2024 | -9.63% |
| Sep 30, 2024 | -29.20% |
| Jun 30, 2024 | -27.23% |
| Mar 31, 2024 | 1.02% |
| Dec 31, 2023 | 25.13% |
| Sep 30, 2023 | -40.26% |
| Jun 30, 2023 | -27.46% |
| Mar 31, 2023 | -29.08% |
| Dec 31, 2022 | -20.79% |
| Sep 30, 2022 | -1.49% |
| Jun 30, 2022 | -2.71% |
| Mar 31, 2022 | -2.53% |
| Dec 31, 2021 | 5.59% |
| Sep 30, 2021 | 2.64% |
| Jun 30, 2021 | 5.59% |
| Mar 31, 2021 | 14.45% |
| Dec 31, 2020 | 7.31% |
| Sep 30, 2020 | 17.40% |
| Jun 30, 2020 | 12.13% |
| Mar 31, 2020 | 22.88% |
| Dec 31, 2019 | 6.73% |
| Sep 30, 2019 | 21.71% |
| Jun 30, 2019 | 18.80% |
| Mar 31, 2019 | 5.83% |
| Dec 31, 2018 | -37.18% |
| Sep 30, 2018 | 18.31% |
| Jun 30, 2018 | 16.57% |
| Mar 31, 2018 | 20.55% |
| Dec 31, 2017 | 16.26% |
| Sep 30, 2017 | 7.31% |
| Jun 30, 2017 | 5.92% |
| Mar 31, 2017 | 2.47% |
| Dec 31, 2016 | 11.21% |
| Sep 30, 2016 | 3.38% |
| Jun 30, 2016 | 10.07% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 24.99% |
| Sep 30, 2015 | -54.02% |
| Jun 30, 2015 | -33.24% |